ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ANI Pharmaceuticals (ANIP – Research Report), Abeona...

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Abeona Therapeutics (ABEO) and Akebia Therapeutics (AKBA)

Guggenheim analyst Vamil Divan reiterated a Buy rating on ANI Pharmaceuticals yesterday and set a price target of $115.00. The company’s shares clo...

Guggenheim Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)

The latest update is out from ANI Pharmaceuticals ( ($ANIP) ). On January 12, 2026, ANI Pharmaceuticals reported strong preliminary, unaudited resu...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANIP	$79.48	-0.65%	167.58K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANIP	$79.48	-0.6%	167.58K
3
4
5
6

ANIP

ANIP

Get ANI Pharmaceuticals Inc. Data in Excel

Get ANI Pharmaceuticals Inc. Data in Excel